Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

DARE Relative to the S&P 500

DARE Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Dare Bioscience, Inc. (NASD:DARE) seasonal charts above shows that a Buy Date of December 20 and a Sell Date of March 19 has resulted in a geometric average return of 25.51% above the benchmark rate of the S&P 500 Total Return Index over the past 11 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 11 years by an average of 74.56% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Dar Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women’s reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley on November 28, 2005 and is headquartered in San Diego, CA.

To download DARE seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: DARE